glp-1 agonists oral FDA just approved orforglipron (Foundayo), Eli Lilly's receptor agonist for obesity. In the ATTAIN-1 phase 3 trial (n=3,127), published in the New England Journal of Medicine, patients on the highest Orforglipron, an Oral Small-Molecule GLP-1

This article will break down the differences between L-glutamine and glutathione, how they interact, and why the way you take them matters just as much as the ingredients themselves

Endpoints for clinical trials in ophthalmology

Retatrutide: The Triple Receptor Compound The compound at the center of this shift, retatrutide, hits three receptors at once: GLP-1, GIP, and glucagon

Ruiz-Maldonado R, Tamayo L, Laterza AM, Durn C

To perform this operation, your doctor must cut through multiple layers of nerve endings, muscular tissue and flesh

Glutathione is a master antioxidant, helping to recycle Vitamin C & E, as well as fighting free radicals itself